Category Archives: Biotechnology

IUBP Day5 2 Emerging Opportunities in Biotechnology M t. By: Vu Tien Thinh … Continue reading →

"Bioscience" redirects here. For the scientific journal, see BioScience. Biotechnology is the use of living systems and organisms to develop or make useful products, or "any technological application that uses biological systems, living organisms or derivatives thereof, to make or modify products or processes for specific use" (UN Convention on Biological Diversity, Art. 2).[1] Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering and biomedical engineering. For thousands of years, humankind has used biotechnology in agriculture, food production, and medicine.[2] The term itself is largely believed to have been coined in 1919 by Hungarian engineer Kroly Ereky. In the late 20th and early 21st century, biotechnology has expanded to include new and diverse sciences such as genomics, recombinant gene technologies, applied immunology, and development of pharmaceutical therapies and diagnostic tests.[3] The wide concept of "biotech" or "biotechnology: encompasses a wide range of procedures (and history) for modifying living organisms according to human purposes, going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization. Modern usage also includes genetic engineering as well as cell and tissue culture technologies. The American Chemical Society defines … Continue reading →

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products. Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes. Currently, there are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases. More than 13.3 million farmers around the world use agricultural biotechnology to increase yields, prevent damage from insects and pests and reduce farming's impact on the environment. And more than 50 biorefineries are being built across North America to test and refine technologies to produce biofuels and chemicals from renewable biomass, which can help reduce greenhouse gas emissions. Recent advances in biotechnology are helping us prepare for and meet societys most pressing challenges. Here's how: Biotech is helping toheal the worldby harnessing nature's own toolbox … Continue reading →

Pamela Peters, from Biotechnology: A Guide To Genetic Engineering. Wm. C. Brown Publishers, Inc., 1993. Biotechnology in one form or another has flourished since prehistoric times. When the first human beings realized that they could plant their own crops and breed their own animals, they learned to use biotechnology. The discovery that fruit juices fermented into wine, or that milk could be converted into cheese or yogurt, or that beer could be made by fermenting solutions of malt and hops began the study of biotechnology. When the first bakers found that they could make a soft, spongy bread rather than a firm, thin cracker, they were acting as fledgling biotechnologists. The first animal breeders, realizing that different physical traits could be either magnified or lost by mating appropriate pairs of animals, engaged in the manipulations of biotechnology. What then is biotechnology? The term brings to mind many different things. Some think of developing new types of animals. Others dream of almost unlimited sources of human therapeutic drugs. Still others envision the possibility of growing crops that are more nutritious and naturally pest-resistant to feed a rapidly growing world population. This question elicits almost as many first-thought responses as there are … Continue reading →

Theme: Biotechnology: Meeting the Needs of a Changing World OMICS Group is dedicated to serve the scientific community through its 350 leading Open Access peer reviewed Journals supported by 30,000 renowned editorial board and more than .5 million reader worldwide. OMICS Group Conferences is proud to host around 100 international conferences around the globe to address the current issues and discoveries in the field of Life sciences, Applied Science & Engineering, Omics and Management, Clinical, Medical and Pharmaceutical sciences. OMICS Scientific events are the special designed cluster of program that provides a common platform where industry meets academia to discuss the recent advancements. OMICS Group International Congresses serve as a bridge between researchers from academia and industry enhanced by its well organized scientific sessions, plenary lectures, poster presentations, world class exhibitions, diverse International Symposiums, highly enriched International Workshops and B2B meetings. OMICS Group Conferences feel proud in inviting the contributors across the globe to its premier 5th World Congress on Biotechnology (Biotechnology-2014) to be held during June 25-27, 2014 at Valencia, Spain. The previous four World Biotechnology Congresses were held at Hyderabad-India, Philadelphia-USA, Hyderabad-India and Raleigh-USA had achieved a grand success. Now it is the time for the 5th World … Continue reading →

Investors pulled a record $372 million from the biggest biotechnology exchange traded fund in its worst day of redemptions ever. The withdrawals from the iShares Nasdaq Biotechnology ETF on April 4 were the most since its 2001 inception, with 7.5 percent of the funds $4.98 billion in total assets leaving what is the biggest biotech-focused ETF, according to data compiled by Bloomberg. It follows a lengthy run-up in biotechnology industry stocks. Now, that momentum money is being sucked out, said Geoffrey Porges, an analyst with Sanford C. Bernstein & Co. in New York, in a telephone interview. Health-care ETFs have boomed this year, attracting more deposits than any other sector and adding $3.98 billion since January 1. That increase has been spurred by a biotechnology sector that last year gained 74 percent, compared with a 30 percent increase in the Standard & Poors 500 Index. ETFs are investment funds that can hold stocks, bonds, commodities or other securities that trade on an exchange and typically track an index. Theyve grown in popularity among investors because of their tradability, low cost relative to mutual funds and tax efficiency. Recently, investors have begun to question whether biotechnology stocks are in a bubble … Continue reading →

Biotechnology Industry Organization (BIO) Posted on: 09 Apr 14 The Biotechnology Industry Organization (BIO) announced today its selection of Congresswoman Renee Ellmers (R-NC) as Legislator of the Year for 2013-2014. Representative Ellmers received the award last night in conjunction with BIO Legislative Day Fly-In. As a champion of America's biotechnology industry Congresswoman Ellmers has distinguished herself for leadership and support of a number of critically important issues including Medicare Part B Medicare Part D and the release of sequestered of FDA user fees" said BIO President and CEO Jim Greenwood."Her important work on the Energy & Commerce Committees Health Subcommittee enables biotech companies to bring life-saving and life-enhancing technologies to market while ensuring America remains the world leader in life science innovation. "The life science industry in North Carolina provides more than $59 billion in annual economic impact and provides jobs both directly and indirectly for over 228000 people.Congresswoman Ellmers has been an invaluable resource for the biotechnology community both in the 2nd District and North Carolina at large said Sam Taylor President of the North Carolina Biosciences Organization."We thank Congresswoman Ellmers for her outstanding leadership and dedication to supporting the innovative capacity and job creating potentialof American life science … Continue reading →

Plant biotechnology 3 For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html. By: Suman Bhattacharjee … Continue reading →